跳至主要内容
临床试验/EUCTR2012-001548-23-NL
EUCTR2012-001548-23-NL进行中(未招募)不适用

An open label study with objective sleepregistration on the effects of Doxazosin as treatment for PTSD, especially for sleep disturbance - DoPS

ParnassiaBavoGroup0 个研究点开始时间: 2012年8月30日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Good speaking and writing in Dutch
  • - PDS above 18
  • - CAPS recurrent distressing dreams item score above 5
  • - CAPS difficulty falling or staying asleep item above 5
  • - No medication except contraceptives or analgetics like paracetamol
  • - No alcohol more than two consumptions a day
  • - Medication use of psychotropics has stopped at least one month before entrance of the study
  • - If psychotherapy has not been started yet it will not be initiated during the trial; If started it will be paused for the period of the study. Medication with influence on sleep-EEG will not be started during the study period (paracetamol and contraceptives are allowed).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Psychiatric:
  • -Lifetime schizophrenia,
  • -schizoaffective disorder,
  • -bipolar disorder,
  • -severe depressive disorder (MADRS > 34) (for screening: QIDS > 15)
  • -cognitive disorder,
  • -current delirium,
  • -substance use within 2 months of the study; alcohol is allowed if not more than 2 consumptions a day.
  • -severe psychiatric instability (including evidence of being actively suicidal or homicidal).
  • -any behavior which poses an immediate danger to patient or others.
  • -preexisting hypotension or (anamnestic) orthostatic hypotension
  • -hypertension unless stable with help of anti-hypertensive medication.
  • -Known for severe ischaemic heart disease
  • -disease with strong reduced functioning of the liver.
  • -Women of childbearing potential with either positive pregnancy test or refusal to use effective birth control method.
  • -Allergy or previous adverse reaction to doxazosin or other alpha-1 antagonist.
  • -Hypersensitivity to quinazolinderivates
  • -Known for hypertrophy of the prostate without treatment.
  • -Gastro-intestinal obstruction
  • -oesophageal obstruction
  • -overflow bladder or anuria with or without progressive renal insufficiency

研究者

发起方
ParnassiaBavoGroup

相似试验